Alphatec Holdings, Inc.
NASDAQ:ATEC · NASDAQ Global Select
+$0.33 today
Vol 4.23M · Avg 3.21M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:ATEC · Revenue to Net Income
Key Ratios
Analysis
$787.1M of revenue converted into -$125.4M of net income for the selected period. Gross margin is 65.4% and net margin is -16.1%, showing how much revenue survives after costs and taxes. EPS is $-0.83, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $764.2M +25.0% | $611.6M +26.8% | $482.3M +37.4% | $350.9M +44.3% | $243.2M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $232.3M +24.0% | $187.3M +8.9% | $172.1M +46.1% | $117.8M +37.9% | $85.5M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $531.9M +25.4% | $424.3M +36.8% | $310.2M +33.1% | $233.1M +47.7% | $157.8M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 69.6% +0.2pp | 69.4% +5.1pp | 64.3% -2.1pp | 66.4% +1.6pp | 64.9% | 9.8% | 28.9% | 38.3% |
| Research & Development | $76.3M -5.5% | $80.7M +15.1% | $70.1M +59.2% | $44.0M +37.5% | $32.0M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $498.5M +10.7% | $450.2M +20.3% | $374.1M +24.7% | $300.0M +30.9% | $229.3M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $614.0M +9.6% | $560.4M +15.9% | $483.6M +27.3% | $380.0M +33.0% | $285.8M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $82.6M -0.9% | $83.3M +39.6% | $59.7M +35.9% | $43.9M +45.6% | $30.2M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$39.7M +26.3% | -$53.9M +51.3% | -$110.6M -7.8% | -$102.6M +4.0% | -$106.9M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -5.2% +3.6pp | -8.8% +14.1pp | -22.9% +6.3pp | -29.2% +14.7pp | -43.9% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$82.1M +39.7% | -$136.2M +21.5% | -$173.4M -18.0% | -$147.0M -14.8% | -$128.1M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -10.7% +11.5pp | -22.3% +13.7pp | -36.0% +5.9pp | -41.9% +10.8pp | -52.7% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $21.1M -15.0% | $24.9M +49.5% | $16.6M +202.3% | $5.5M -22.6% | $7.1M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$61.3M -136.5% | -$25.9M -91.6% | -$13.5M -168.6% | -$5.0M +68.7% | -$16.1M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$143.4M +11.5% | -$162.1M +13.3% | -$186.9M -23.0% | -$152.0M -5.4% | -$144.2M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -18.8% +7.7pp | -26.5% +12.3pp | -38.8% +4.6pp | -43.3% +16.0pp | -59.3% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$45.0K -190.0% | $50.0K +118.1% | -$277.0K +61.3% | -$716.0K +36.6% | -$1.1M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$143.4M +11.6% | -$162.1M +13.1% | -$186.6M -23.4% | -$151.3M -5.8% | -$143.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | -18.8% +7.7pp | -26.5% +12.2pp | -38.7% +4.4pp | -43.1% +15.7pp | -58.8% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$1 +15.0% | -$1 +26.6% | -$2 -4.8% | -$1 +2.0% | -$2 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$1 +15.0% | -$1 +26.6% | -$2 -4.8% | -$1 +2.0% | -$2 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $150.1M +5.0% | $142.9M +17.9% | $121.2M +17.3% | $103.4M +7.5% | $96.2M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $150.1M +5.0% | $142.9M +17.9% | $121.2M +17.3% | $103.4M +7.5% | $96.2M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Cidara Therapeutics, Inc.
CDTX
$5.61B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.54B
Legend Biotech Corporation
NASDAQ:LEGN
$5.33B
LivaNova PLC
NASDAQ:LIVN
$4.35B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.92B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.85B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.76B
Disc Medicine, Inc.
NASDAQ:IRON
$2.68B
Zai Lab Limited
NASDAQ:ZLAB
$2.07B
Surgery Partners, Inc.
NASDAQ:SGRY
$1.87B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does ATEC generate?
Alphatec Holdings, Inc. (ATEC) reported $764.15M of revenue in fiscal 2025.
Is ATEC profitable?
Alphatec Holdings, Inc. (ATEC) reported -$143,358,000.00 of net income, with a net margin of -18.8%.
Explore More
Continue the stock analysis
Jump to another research area for this company.